Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
AVROBIO, Inc. (AVRO) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/12/2023 8-K Quarterly results
06/12/2023 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Departure of Directors or...
Docs: "Unaudited pro forma condensed combined financial information of AVROBIO, Inc. (giving effect to the Asset Sale) as of and for the three months ended March 31, 2023 and for the year ended December 31, 2022 and the notes related thereto",
"AVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 Million"
06/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/18/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis at the ASGCT 26 th Annual Meeting",
"AVROBIO, Inc. slide presentation"
05/11/2023 8-K Quarterly results
Docs: "AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update"
05/01/2023 8-K Quarterly results
03/23/2023 8-K Quarterly results
Docs: "AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update"
02/27/2023 8-K Other Events  Interactive Data
12/07/2022 8-K Quarterly results
11/08/2022 8-K Quarterly results
Docs: "Provides Business Update"
10/07/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/09/2022 8-K Quarterly results
06/29/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/24/2022 8-K Quarterly results
05/18/2022 8-K Quarterly results
05/17/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
03/17/2022 8-K Quarterly results
Docs: "AVROBIO Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update"
02/09/2022 8-K Quarterly results
01/07/2022 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
01/04/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "AVROBIO Reprioritizes Pipeline Programs",
"AVROBIO, Inc. slide presentation, dated January 2022"
11/04/2021 8-K Quarterly results
Docs: "AVROBIO Reports Third Quarter 2021 Financial Results and Provides Business Update"
10/19/2021 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "AVROBIO Reports New Interim Safety Data Across Investigational Gene Therapies for Fabry and Gaucher Disease Type 1",
"AVROBIO, Inc. slide presentation"
08/09/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
06/17/2021 8-K Quarterly results
06/14/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
05/03/2021 8-K Quarterly results
03/23/2021 8-K Quarterly results
03/18/2021 8-K Quarterly results
02/08/2021 8-K Quarterly results
01/11/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy